University of Cambridge > > Cambridge Cardiovascular Seminar Series > Cardiac regenerative therapy–is it viable?

Cardiac regenerative therapy–is it viable?

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Denise Hatherly.

Speaker’s Bio

Dr. Nakamura’s translational research focuses on pluripotent stem cell-based cardiac remuscularization using various preclinical models to optimize the efficacy and safety of cardiomyocyte transplantation. Clinically, he performs complex coronary interventions and leads novel gene- and cell-based clinical trials for the University of Washington. Dr. Nakamura obtained his medical degree at the University of California, San Francisco, and clinical training at the Massachusetts General Hospital/Harvard Medical School with post-doctoral studies at the Massachusetts Institute of Technology. He runs the large animal studies for (previously Sana Biotechnology) and for Chuck Murry, including edited cell therapy and trials on gene therapy.

This talk is part of the Cambridge Cardiovascular Seminar Series series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2024, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity